Two children with skin rash and muscle weakness: Juvenile dermatomyositis;Twee kinderen met huiduitslag en spierzwakte: Juveniele dermatomyositis

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 3, 2005, Pages 146-150

  Boogaard, R ^a,b   Drexhaije, V R ^b   Van Suijlekom Smit, L W A ^b  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MUSCLE ENZYME;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DRUG CHOICE; ELECTROMYOGRAM; FEMALE; HUMAN; JUVENILE DERMATOMYOSITIS; MALAISE; MUSCLE BIOPSY; MUSCLE STRENGTH; MUSCLE WEAKNESS; PRESCHOOL CHILD; RASH; STEROID THERAPY;

ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; DERMATOMYOSITIS; DRUG THERAPY, COMBINATION; FACE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MUSCLE, SKELETAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 12244277431     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003;49:300-5.
2. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
3. Cassidy JT, Petty RE. Juvenile dermatomyositis. In: Cassidy JT, Petty RE, editors. Textbook of pediatric rheumatology. Philadelphia: Saunders; 2001. p. 465-504.
4. Pachman LM. Juvenile dermatomyositis: immunogenetics, pathophysiology, and disease expression. Rheum Dis Clin North Am 2002; 28:579-602, vii.
5. Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002;28:833-57.
6. Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA, Fink CW, et al. Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol 1998;25:1198-204.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
8. Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43:1866-73.
9. Plamondon S, Dent PB. Juvenile amyopathic dermatomyositis: results of a case finding descriptive survey. J Rheumatol 2000;27:2031-4.
10. Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999;42:2213-9.
11. Reed AM, Lopez M. Juvenile dermatomyositis: recognition and treatment. Paediatr Drugs 2002;4:315-21.
12. Sansome A, Dubowitz V. Intravenous immunoglobulin in juvenile dermatomyositis - four year review of nine cases. Arch Dis Child 1995;72:25-8.
13. Al-Mayouf SM, Laxer RM, Schneider R, Silverman ED, Feldman BM. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 2000;27:2498-503.
14. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329: 1993-2000.
15. Bitnum S, Daeschner jr CW, Travis LB, Dodge WF, Hopps HC. Dermatomyositis. J Pediatr 1964;64:101-31.
16. Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Mallesen P, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43:541-9.
17. Miller LC, Michael AF, Kim Y. Childhood dermatomyositis. Clinical course and long-term follow-up. Clin Pediatr (Phila) 1987;26:561-6.
18. Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 2002;47:505-11.